John R. Schoenfelder

Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline.

Beverly M. K. Biller, Mark E. Molitch, M. L. Vance et al. · The Journal of Clinical Endocrinology & Metabolism · 1996 · 195 citations · Full text

Molecular Pharmacology, Prolactin-secreting Macroadenomas, Clinical Therapeutic +8

Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancer.

Charles L. Vogel, John R. Schoenfelder, Irving Shemano et al. · Journal of Clinical Oncology · 1995 · 123 citations

Multicenter phase II efficacy trial of toremifene in tamoxifen-refractory patients with advanced breast cancer.

Charles L. Vogel, Irving Shemano, John R. Schoenfelder et al. · Journal of Clinical Oncology · 1993 · 114 citations

Early Manifestations of Disseminated<i>Mycobacterium avium</i>Complex Disease: A Prospective Evaluation

Fred M. Gordin, David L. Cohn, Paul M. Sullam et al. · The Journal of Infectious Diseases · 1997 · 51 citations · Full text

Medical Microbiology, Microbial Disease, Elevated Lactate Dehydrogenase +13

Multicenter study of cabergoline, a long‐acting dopamine receptor agonist, in Parkinson's disease patients with fluctuating responses to levodopa/carbidopa

A. Lieberman, Susan Imke, Manfred D. Muenter et al. · Neurology · 1993 · 41 citations